Phase 2 study of ISA101b (peltopepimut-S) and cemiplimab in patients with advanced HPV16+ oropharyngeal cancer who failed anti-PD1 therapy
Kong, Anthony H, Klein Hesselink, Marielle S, Aguilera, Begoña, Adkins, Douglas, Even, Caroline, Fayette, Jerome, Muzaffar, Jameel, Visscher, Sonja, Melief, Cornelis JM, Hooftman, Leon W.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Dose escalation of POL6326 in combination with eribulin in HER2-negative relapsed metastatic breast cancer (mBCa) patients (pts)
Pernas Simon, Sonia, Cortes, Javier, Ademuyiwa, Foluso Olabisi, Lopez-Tarruella, Sara, Manso, Luis, Kaufman, Peter, Hooftman, Leon W., Romagnoli, Barbara, Perez-Fidalgo, Jose Alejandro, Pluard, Timothy J., Weilbaecher, Katherine N., Gomez Pardo, Patricia
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase I study of the combination of balixafortide (CXCR4 inhibitor) and eribulin in HER2-negative metastatic breast cancer (MBC) patients (pts)
Gil-Martin, Marta, Gomez Pardo, Patricia, Lopez-Tarruella, Sara, Manso, Luis, Perez-Fidalgo, Jose Alejandro, Ademuyiwa, Foluso Olabisi, Mayer, Ingrid A., Pluard, Timothy J., Martinez Garcia, Maria, Kaufman, Peter A., Vahdat, Linda T., Hooftman, Leon W., Romagnoli, Barbara, Hernando, Cristina, Weilbaecher, Katherine N., Ciruelos, Eva M., Martin, Miguel, Pernas Simon, Sonia, Cortes, Javier
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article